Imunon to effect 1-for-15 reverse stock split on July 25, 2025 to maintain Nasdaq listing

Imunon, Inc.

Reverse split at 1-for-15 ratio effective 12:01 a.m. ET on July 25, 2025.
Outstanding shares to drop from ~31.8M to ~2.1M; fractional shares rounded up.
Split intended to comply with Nasdaq minimum bid price continued listing requirement.
Stock to trade under existing ticker IMNN with new CUSIP 15117N701.
Board set ratio on July 11, 2025; stockholders authorized range of 1-for-5 to 1-for-18.

item 3.03 item 5.03 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Imunon, Inc.: Amended Restated Certificate of Incorporation to effect a 1-for-15 reverse stock split of common stock (effective 2025-07-25).

Change: charter amendment
Effective: 2025-07-25

Exact text from the filing

On July 21, 2025, Imunon, Inc. (the “Company”) filed a Certificate of Amendment (the “Amendment”) to its Restated Certificate of Incorporation (as amended to date, the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware to effect a one-for-fifteen (1-for-15) reverse stock split (the “Reverse Stock Split”) of its outstanding common stock, par value $0.01 per share (the “Common Stock”). The Reverse Stock Split will become effective on July 25, 2025 at 12:01 a.m. Eastern Time (the “Effective Time”).

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Imunon, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-020652

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.